| ID: | 205 | |
|---|---|---|
| Name: | Compound 205 | |
| Description: | Original numeration in publication: 6e | |
| Labels: | Training_set, Phthalazines | |
| CAS: | ||
| InChi Code: | InChI=1S/C16H10Cl2N6/c17-13-6-3-7-14(18)12(13)8-19-21-15-10-4-1-2-5-11(10)16-22-20-9-24(16)23-15/h1-9H,(H,21,23)/b19-8+ |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 5.81 |
El-Helby, A.-G. A.; Ayyad, R. R. A.; Sakr, H. a. E.-A., K.; Ali, M. M.; Khedr, F. Design, synthesis, molecular docking, and anticancer activity of phthalazine derivatives as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2017, 350, 1700240. https://doi.org/10.1002/ardp.201700240 |
| 5.62494 |
Eq1: VEGFR-2 inhibition (Data used to train model) |